we are all assuming the genetic will sell for nothing?
and therefore Lilly is going to compete with give away prices.
from what i known going to the chemist, generic are a fraction less than the original and therefore most time go for the original.
it will not be difficult to hold a reasonable market share IMO
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX, page-51
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.44M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 141351 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 73455 | 1 |
View Market Depth
| Last trade - 10.45am 10/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable